Home - Products - Others - Other Targets - Capecitabine-2,3-cyclic Carbonate

Capecitabine-2,3-cyclic Carbonate

CAS No. 921769-65-5

Capecitabine-2,3-cyclic Carbonate( —— )

Catalog No. M35773 CAS No. 921769-65-5

Capecitabine-2',3'-cyclic Carbonate is a antiproliferative agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 38 In Stock
50MG 52 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Capecitabine-2,3-cyclic Carbonate
  • Note
    Research use only, not for human use.
  • Brief Description
    Capecitabine-2',3'-cyclic Carbonate is a antiproliferative agent.
  • Description
    Capecitabine-2',3'-cyclic carbonate (Compd 5a) is a 5'-deoxy-5-fluorocytidine derivative with anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    921769-65-5
  • Formula Weight
    385.34
  • Molecular Formula
    C16H20FN3O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N([C@H]2[C@]3([C@@]([C@@H](C)O2)(OC(=O)O3)[H])[H])C=C(F)C(NC(OCCCCC)=O)=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. V.?Jhansi Rani, et al. Synthesis and biological activity evaluation of cytidine-5′-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2′,3′-carbonates.European Journal of Medicinal Chemistry.Volume 54,?August 2012, Pages 690-696.
molnova catalog
related products
  • Demethoxydeacetoxyps...

    Demethoxydeacetoxypseudolaric acid B analog has potent activities against HMEC-1, HL-60, A-549, MB-MDA-468, BEL-7402, HCT116, and Hela cells with IC50s ranging from 0.136 to 1.162 μM. and is semi-synthesized by efficient routines from Pseudolaric acid B.

  • Itolizumab

    Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that targets the extracellular SRCR distal domain 1 of CD6, thereby slowing T cell proliferation and inhibiting pro-inflammatory cytokine production.

  • Trioxsalen

    Trioxsalen is a furanocoumarin and a psoralen derivative, in conjunction with UV-A for phototherapy treatment of vitiligo and hand eczema.